Kelyniam Global, Inc. (KLYG)
OTCMKTS · Delayed Price · Currency is USD
0.0900
0.00 (0.00%)
Oct 14, 2025, 8:00 PM EDT
Kelyniam Global Market Cap
Kelyniam Global has a market cap or net worth of $4.53 million as of October 16, 2025. Its market cap has increased by 103.11% in one year.
Market Cap
4.53M
Enterprise Value
n/a
Revenue
2.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since April 3, 2008, Kelyniam Global's market cap has decreased from 5.24M to 4.53M, a decrease of -13.63%. That is a compound annual growth rate of -0.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 4.53M | -41.99% |
| Dec 31, 2024 | 7.80M | 327.63% |
| Dec 28, 2023 | 1.83M | -24.53% |
| Dec 27, 2022 | 2.42M | -4.56% |
| Dec 31, 2021 | 2.53M | -37.32% |
| Dec 28, 2020 | 4.04M | 49.66% |
| Dec 17, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 698.88M |
| Elite Pharmaceuticals | 663.06M |
| Veradigm | 514.01M |
| Nika Pharmaceuticals | 495.49M |
| Northwest Biotherapeutics | 356.04M |
| CytoDyn | 350.21M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 275.85M |